Bildkälla: Stockfoto

Biovica: Potential near-term market expansion - Redeye

Biovica announces that the study from Karolinska indicates robust clinical support for expanding future use of DiviTum to monitoring response to immunotherapy for patients with metastatic cutaneous melanoma.

Biovica announces that the study from Karolinska indicates robust clinical support for expanding future use of DiviTum to monitoring response to immunotherapy for patients with metastatic cutaneous melanoma.
Börsvärldens nyhetsbrev
ANNONSER